ADIPOQ and pulmonary arterial hypertension: In a case–control study, Santos et al. demonstrated higher circulating adiponectin values in PAH patients than in controls (12.4 ± 6.9 vs. 8.1 ± 4.5 μg/mL; p < 0.05).